TB CAB

Response to TB treatment trials results published and presented during the 2022 Union World Conference on Lung Health

Statement by Treatment Action Group (TAG) and the Global Tuberculosis Community Advisory Board (TB CAB)

Read More →

Updates required to the National TB guidelines to support access to shorter regimens as a human right in India

Advocates demand that the Indian government take urgent action to ensure that every eligible person with TB has access to evidence-based, short-course treatment regimens.

Read More →

International support for compulsory license to address access barriers to life-saving TB medicines

Advocates urge the Indian government to issue compulsory licenses for patents on bedaquiline and delamanid to make the drugs more affordable and accessible.

Read More →

Call for new Global TB CAB members from Russia, Brazil, Indonesia, the Philippines

Deadline for applications: 19 February 2021

Read More →

TB CAB Statement

TB CAB Access Considerations Statement Regarding Johnson & Johnson Announcement of Bedaquiline Price Reduction

Read More →

Crisis of confidence in the WHO's ability to produce normative guidance for the treatment of RR-/MDR-TB

Advocates request an urgent in-person meeting with the WHO leadership to discuss concrete actions to address technical and guideline development process-related issues previously raised.

Read More →

Research, regulatory, and access considerations regarding pretomanid

TB CAB releases document outlining key considerations regarding pretomanid in anticipation of FDA public advisory committee meeting on the TB Alliance's new drug application for pretomanid.

Read More →

Advocates raise serious concerns about errors in the WHO guidelines for the treatment of drug-resistant TB

Advocates call on WHO leadership to act immediately and correct specific technical errors in the WHO guidelines for the treatment of drug-resistant TB.

Read More →

TB CAB statement on M72/AS01E TB vaccine candidate development

Statement by the Global TB Community Advisory Board to the High-level consultation on accelerating the development of the M72/AS01E tuberculosis vaccine candidate

Read More →

TB CAB statement on safety of using bedaquiline and delamanid together

Global TB CAB welcomes confirmation of safety of using bedaquiline and delamanid together, urges uptake.

Read More →

Page 1 of 6 · Total posts: 10

1 2 Last→